Biological Aging
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Elysium TherapeuticsOH - Akron
1 programThe Translational Initiative to Map Epigenetics in Aging (TIME-A)N/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Elysium TherapeuticsThe Translational Initiative to Map Epigenetics in Aging (TIME-A)
AbbottCatechin Cohort 1
Clinical Trials (2)
Total enrollment: 25,039 patients across 2 trials
The Translational Initiative to Map Epigenetics in Aging (TIME-A)
Start: Mar 2023Est. completion: Mar 203325,000 patients
N/ANot Yet Recruiting
Effects of Phytonutrients Upon Muscle Perfusion in Response to Feeding
Start: Sep 2017Est. completion: Oct 201939 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.